Updated September 2026A daily rate on the wrong pageDirect Meds review
Everything is sold by the quarter and quoted by the day. One of the daily figures is the other molecule's.
The verdict
Direct Meds contradicts itself in public. Its tirzepatide page carries two daily rates. Only one agrees with the price beside it. The other is the semaglutide figure, transplanted. Every headline is hedged 'as low as' on top of that, read August 2026.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $297/mo
- Oral
- From $249/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- Not published by the provider
Direct Meds runs a portal rather than a storefront. Both molecules appear in both routes. Every line is sold as a multi-month supply. The pages state which: twelve weeks for the injections, thirteen for the tablets.
Who writes the prescription, and what do they see?
The prescription is arranged through the portal. A clinician reviews an intake before dispensing. The pages state flow codes and supply lengths rather than describing the clinician. What the intake asks is not published.
No line is sold by the calendar month, though every figure is presented as one. What is bought is a supply block. The pages disclose its length beside a flow code rather than in the price. The daily framing shrinks the number a reader sees. It also conceals what is owed at purchase.
What happens when the dose goes up?
No line says what its figure does at a higher dose. One oral tier runs against the category's habit. Certain dosages fall below the advertised number rather than above it. That makes the headline a ceiling. Unusual, and disclosed rather than discovered.
What the price includes
Check the daily figures before trusting any of them. Only one of the two on the tirzepatide page reconciles with that page's own price; the other reproduces the semaglutide arithmetic. A pricing page carrying an error about its own product is a reason to confirm every number on it directly.
What it claims, and what it cites
Each line is compounded. Nothing here is FDA-approved, and no agency examines it before it ships. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Supply length appears beside every figure
- Strength: Flow codes are visible in the portal
- Strength: One oral tier undercuts its own headline
- Limitation: One published daily rate contradicts its own price
- Limitation: The quoted unit is not the billed unit
- Limitation: Every figure carries an unexplained hedge
- Limitation: Nothing describes a higher dose
What the evidence says about this kind of treatment
The assessment above is about Direct Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will verify each number against the portal before ordering.
- Wrong for
- A reader who wants to buy a single month of anything.
How Direct Meds compares
| Seller | Who it suits | Go |
|---|---|---|
| GobyMeds | Readers who can pay twelve weeks at once and want the extras inside one figure | See GobyMeds → |
 June Health | Readers who want the escalation priced before enrolling rather than met in month three | See June Health → |
| NuvaHealth | Readers prepared to reach checkout before learning the standing rate | See NuvaHealth → |
More GLP-1 telehealth sellers reviews: AgelessRxAlan MedsAlloyAlyveRxApex MDAquaVita NextGen
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Which daily figure is correct for tirzepatide?
- The higher of the two. It reconciles with that page's own price; the lower one reproduces the semaglutide arithmetic.
- Is a month available?
- No line is sold by the calendar month. Each is a multi-month supply block, and the pages state the length beside a flow code.
- Why does the oral price below its headline?
- Certain dosages fall below the advertised number rather than above it, which makes that headline a ceiling on the line.
- Is Direct Meds expensive compared with other GLP-1 telehealth sellers?
- Direct Meds publishes a starting figure of $249/mo. Across the 83 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Direct Meds above the median. The other 5 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.